Africa Sidesteps FDA’s Warning on J&J Vaccine as Cases Surge

Africa, the continent with the world’s lowest vaccination rate, is going ahead with plans to procure Johnson & Johnson’s Covid-19 vaccine undeterred by the U.S. Food and Drug Administration’s warning about the inoculation.

The FDA earlier this month said that it was adding a warning to J&J’s vaccine fact sheet after 100 reports of Guillain-Barré Syndrome, a rare condition in which the immune system attacks the nerves, among people who had received the shot.